Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of Over 30% - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jun 13, 2018--The “Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery, Target, Product and End User - Global Opportunity Analysis and Industry Forecast, 2017-2023” report has been added to ResearchAndMarkets.com’s offering.
The Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market was valued at $144 million in 2016, and is expected to reach $912 million by 2023, registering a CAGR of 30.1% from 2017 to 2023.
Minimally invasive glaucoma surgery (MIGS) devices can be are employed in any glaucoma surgery that avoids conjunctival dissection, and includes an ab interno incision for the treatment of patients suffering from glaucoma. The advent of MIGS devices has transformed the patients care with mild-to-moderate glaucoma conditions. In addition, improved safety profile as well as less time required for recovery after surgery as compared to more invasive techniques increases the demand for MIGS devices.
This propels manufacturers to introduce efficient MIGS devices such as stents, shunts, and minimally invasive implants in the market. Moreover, glaucoma is the primary cause of irreversible blindness across the globe, and it was estimated that around 4% of the global population suffered from glaucoma in 2014. This has increased the demand for MIGS devices in the treatment of glaucoma.
Companies Mentioned:Novartis International Ag (Alcon Inc.) Allergan Plc. Ellex Medical Lasers Ltd. Glaukos Corporation Istar Medical Sa Ivantis Inc. Lumenis Ltd. Santen Pharmaceutical Co., Ltd. Solx, Inc.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery
Chapter 5 Minimally Invasive Glaucoma Target (MIGS) Devices Market, By Target
Chapter 6 Minimally Invasive Glaucoma Product (MIGS) Devices Market, By Product
Chapter 7 Minimally Invasive Glaucoma End User (MIGS) Devices Market, By End User
Chapter 8 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Region
Chapter 9: Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/5qqvwh/global_minimally?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180613005447/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Optical,Surgical Devices
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 06/13/2018 04:51 AM/DISC: 06/13/2018 04:51 AM